RU2004134082A - ANTI-GRIPPOINT MEANS - Google Patents

ANTI-GRIPPOINT MEANS Download PDF

Info

Publication number
RU2004134082A
RU2004134082A RU2004134082/15A RU2004134082A RU2004134082A RU 2004134082 A RU2004134082 A RU 2004134082A RU 2004134082/15 A RU2004134082/15 A RU 2004134082/15A RU 2004134082 A RU2004134082 A RU 2004134082A RU 2004134082 A RU2004134082 A RU 2004134082A
Authority
RU
Russia
Prior art keywords
capsule
tablet
excipients
remantadine
loratadine
Prior art date
Application number
RU2004134082/15A
Other languages
Russian (ru)
Other versions
RU2286770C2 (en
Inventor
Евгений Вениаминович Купсин (RU)
Евгений Вениаминович Купсин
Original Assignee
Закрытое акционерное общество "Научно-производственное объединение "Антивирал" (RU)
Закрытое акционерное общество "Научно-производственное объединение "Антивирал"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36656505&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2004134082(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Закрытое акционерное общество "Научно-производственное объединение "Антивирал" (RU), Закрытое акционерное общество "Научно-производственное объединение "Антивирал" filed Critical Закрытое акционерное общество "Научно-производственное объединение "Антивирал" (RU)
Priority to RU2004134082/15A priority Critical patent/RU2286770C2/en
Priority to EA200501621A priority patent/EA008765B1/en
Publication of RU2004134082A publication Critical patent/RU2004134082A/en
Application granted granted Critical
Publication of RU2286770C2 publication Critical patent/RU2286770C2/en

Links

Claims (2)

1. Антигриппозное комплексное лекарственное средство для перорального применения, включающее парацетамол, ремантадин, аскорбиновую кислоту, рутин, лоратадин, кальция глюконат и вспомогательные вещества, при этом активные компоненты разделены по химической совместимости в две капсулы или таблетки, составляющие вместе одноразовую дозу, при следующем соотношении компонентов на одну дозу, мг:1. An anti-influenza complex drug for oral administration, including paracetamol, remantadine, ascorbic acid, rutin, loratadine, calcium gluconate and excipients, while the active components are separated by chemical compatibility into two capsules or tablets, which together form a single dose, in the following ratio components per dose, mg: капсула или таблетка 1:capsule or tablet 1: парацетамол - 324-396,paracetamol - 324-396, вспомогательные вещества - 18-22,excipients - 18-22, капсула или таблетка 2:capsule or tablet 2: ремантадин - 45-55,remantadine - 45-55, аскорбиновая кислота - 270-330,ascorbic acid - 270-330, рутин - 18-22,routine - 18-22, лоратадин - 2,7-3,3,loratadine - 2.7-3.3, кальция глюконат - 90-110,calcium gluconate - 90-110, вспомогательные вещества - 6,3-7,7.excipients - 6.3-7.7. 2. Антигриппозное комплексное лекарственное средство по п.1, включающее в качестве вспомогательных веществ2. The anti-influenza complex drug according to claim 1, including as auxiliary substances в капсуле/таблетке 1:in capsule / tablet 1: крахмал - 8,1-9,9 мг,starch - 8.1-9.9 mg, сахар молочный - 3,8-4,6 мг,milk sugar - 3.8-4.6 mg, магния стеарат - 3,4-4,2 мг,magnesium stearate - 3.4-4.2 mg, кремний диоксид коллоидный - 2,7-3,3 мг,colloidal silicon dioxide - 2.7-3.3 mg, и в капсуле/таблетеке 2:and in capsule / tablet 2: магния стеарат - 4,3-5,3 мг,magnesium stearate - 4.3-5.3 mg, крахмал - 2,0-2,4 мг.starch - 2.0-2.4 mg.
RU2004134082/15A 2004-11-22 2004-11-22 Anti-influenza agent RU2286770C2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
RU2004134082/15A RU2286770C2 (en) 2004-11-22 2004-11-22 Anti-influenza agent
EA200501621A EA008765B1 (en) 2004-11-22 2005-11-16 Antiinflammatory preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2004134082/15A RU2286770C2 (en) 2004-11-22 2004-11-22 Anti-influenza agent

Publications (2)

Publication Number Publication Date
RU2004134082A true RU2004134082A (en) 2006-05-10
RU2286770C2 RU2286770C2 (en) 2006-11-10

Family

ID=36656505

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004134082/15A RU2286770C2 (en) 2004-11-22 2004-11-22 Anti-influenza agent

Country Status (2)

Country Link
EA (1) EA008765B1 (en)
RU (1) RU2286770C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2727592A1 (en) * 2012-11-05 2014-05-07 Kücükgüzel, Sükriye Güniz A combination of desloratadine and paracetamol

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2470144C1 (en) * 2011-05-31 2012-12-20 Иван Викторович Грехов Plant for simultaneous-separate extraction of hydrocarbons
RU2498797C2 (en) * 2012-01-27 2013-11-20 Общество с ограниченной ответственностью "ФармЭталон" Combined preparation for influenza and acute respiratory viral infections
WO2022159763A1 (en) * 2021-01-22 2022-07-28 Model Medicines, Inc. Sars-cov-2 therapeutics

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2084028A1 (en) * 1991-11-27 1993-05-28 Harish B. Pandya Hot flu composition
JPH09502201A (en) * 1993-09-07 1997-03-04 ザ、プロクター、エンド、ギャンブル、カンパニー Composition containing amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of decongestant, expectorant, antihistamine and antitussive agent
AU6599196A (en) * 1995-07-28 1997-02-26 Procter & Gamble Company, The Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
RU2192248C2 (en) * 1998-07-13 2002-11-10 Товарищество с ограниченной ответственностью фирма "Эйкос" Preparation "antiagrippin"
RU2237470C1 (en) * 2003-01-27 2004-10-10 Купсин Евгений Вениаминович Combined preparation for removing symptoms of catarrhal diseases and grippe (variants)
RU2229877C1 (en) * 2003-02-25 2004-06-10 ГУ Научно-исследовательский институт гриппа РАМН Agent for influenza treatment

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2727592A1 (en) * 2012-11-05 2014-05-07 Kücükgüzel, Sükriye Güniz A combination of desloratadine and paracetamol

Also Published As

Publication number Publication date
EA200501621A1 (en) 2006-06-30
RU2286770C2 (en) 2006-11-10
EA008765B1 (en) 2007-08-31

Similar Documents

Publication Publication Date Title
RU2648760C3 (en) PHARMACEUTICAL COMPOSITION CONTAINING IRON OXYHYDROXIDE, METHOD FOR PRODUCING AND APPLICATION
TW200843802A (en) Compositions for improving gastrointestinal nutrient and drug absorption
JP2012255026A5 (en)
JP2009517411A5 (en)
MA29681B1 (en) GALENIC FORMS OF RISEDRONATE
JP2004533999A5 (en)
JP2013511507A5 (en)
WO2007031887A3 (en) Extended release pharmaceutical composition of metformin and a process for producing it
RU2014115287A (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION WITH MASKED TASTE AND METHOD FOR PRODUCING IT
JP2012533565A5 (en)
JP2019218379A5 (en)
RU2007132971A (en) METHODS AND MATERIALS WITH TRANS-CLOMIPHENES FOR TREATMENT OF MEN'S INFERTILITY
RU2006115784A (en) The use of L-butylphthalide for the manufacture of a medicament for the prevention and treatment of cerebral infarction
JP2006342148A5 (en)
RU2010151631A (en) IRON BISGLYCINATE-CHELATE FOR USE IN ORAL TREATMENT OF ANEMIA IN PATIENTS WITH CELIACIA
RU2015143475A (en) PRODUCT AND METHOD FOR TREATING DIARRHEA
RU2007119067A (en) MEANS FOR TREATMENT OF AN IRRITATED INTESTINAL SYNDROME WITH PREVENTION OF DIARRHEA
CN103826644A (en) Oral rehydration composition
RU2004134082A (en) ANTI-GRIPPOINT MEANS
ATE457721T1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING PHARMACEUTICAL ACTIVE INGREDIENTS ABSORBED ON TITANIUM DIOXIDE DNANOPARTICLES
RU2016144695A (en) COMPLEX OF SITAGLIPTIN TANNA
JP2017515858A5 (en)
RU2006122160A (en) Oral Medication for the Replenishment of Magnesium Deficiency in the Body
JP2003523385A5 (en)
RU2003133155A (en) METHOD FOR ERADICATING HELICOBACTER PYLORI INFECTIONS IN THE STOMACH

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20110330

QB4A Licence on use of patent

Free format text: LICENCE

Effective date: 20110826

QB4A Licence on use of patent

Free format text: LICENCE

Effective date: 20111206

QZ41 Official registration of changes to a registered agreement (patent)

Free format text: LICENCE FORMERLY AGREED ON 20110826

Effective date: 20120220

HE4A Notice of change of address of a patent owner
QZ41 Official registration of changes to a registered agreement (patent)

Free format text: LICENCE FORMERLY AGREED ON 20111206

Effective date: 20150326